|
?:authorAffiliation
|
-
[\'Cleveland Clinic, Cleveland, OH.\', \'Harbin Clinic LLC, Rome, GA.\', \'American Society of Clinical Oncology, Alexandria, VA.\', \'University of Michigan, Ann Arbor, MI.\', \'Northwest Medical Specialties, Seattle, WA.\', \'INOVA Medical Group, Fairfax, VA.\', \'Tennessee Oncology, Nashville, TN.\', \'Stanford University, Stanford, CA.\', \'Memorial Sloan-Kettering Cancer Center, New York, NY.\', \'Virginia Mason Medical Center, Seattle, WA.\', \'Bozeman Deaconess Health Services, Bozeman, MT.\', \'Saint Louis University, St Louis, MO.\', \'Dana-Farber/Brigham and Women\'s Cancer Center, Boston, MA.\', \'Cholangiocarcinoma Foundation, Herriman, UT.\', \'University of Rochester, Rochester, NY.\', \'Boston Children\'s Hospital, Boston, MA.\', \'New Mexico Oncology Hematology Consultants, Ltd, Albuquerque, NM.\', \'Seattle Cancer Care Alliance, Seattle, WA.\', \'Levine Cancer Institute, Charlotte, NC.\', \'National Coalition for Cancer Survivorship, Silver Spring, MD.\', \'Mayo Clinic, Rochester, MN.\', \'Gundersen Health System, La Crosse, WI.\', \'Texas Oncology PA, Austin, TX.\', \'Gemini Group, Ann Arbor, MI.\', \'University of Texas MD Anderson Cancer Center, Houston, TX.\', \'START Center for Cancer Care, San Antonio, TX.\', \'University of Washington, Seattle, WA.\', \'The Center for Cancer and Blood Disorders, Fort Worth, TX.\', \'Cancer Research Consortium of West Michigan NCORP, Grand Rapids, MI.\', \'Icahn School of Medicine at Mt. Sinai, Bronxville, NY.\', \'Kaiser Permanente Northern California, Walnut Creek, CA.\', \'Valley Health System, Paramus, NJ.\', \'Intermountain Healthcare, South Jordan, UT.\', \'Michiana Hematology Oncology, Niles, MI.\', \'Association for Clinical Oncology, Alexandria, VA.\', \'Sarah Cannon, Nashville, TN.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}